Avalyn Pharma Inc.

Listed Company
AVLNCIK 0001540171NasdaqEmerging GrowthPharmaceutical PreparationsDelawareGBFY ends Dec 31
AVLN$28.29−2.75% · past 3 monthsDBEQ Basic
Daily closing prices

Business

Avalyn Pharma Inc. is a foreign private issuer in Pharmaceutical Preparations, headquartered in the United Kingdom. Shares trade on Nasdaq under the ticker AVLN.

Auto-generated from company profile

Financials

Financial data not availableThis foreign private issuer reports on 20-F / 40-F; structured XBRL metrics not yet extracted. See the Filings tab for primary-source reports.

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Avalyn Pharma Inc.'s CIK number?

Avalyn Pharma Inc.'s SEC CIK number is 0001540171 (1540171). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Avalyn Pharma Inc.'s SEC filings?

All of Avalyn Pharma Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Avalyn Pharma Inc. last report earnings?

Avalyn Pharma Inc. (AVLN) most recently filed an earnings 8-K with the SEC on Jun 3, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-254581). This is Avalyn Pharma Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is Avalyn Pharma Inc.'s most recent earnings 8-K?

Avalyn Pharma Inc.'s latest earnings 8-K (Item 2.02) was filed Jun 3, 2026 under accession 0001193125-26-254581. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Avalyn Pharma Inc.'s latest earnings 8-K →
Look up any company's CIK number →